Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS
· Delayed Price · Currency is USD
23.90
-0.01 (-0.04%)
Oct 30, 2024, 4:00 PM EDT
Chugai Pharmaceutical Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 982,743 | 974,493 | 1,039,247 | 802,836 | 633,314 | 588,896 | Upgrade
|
Other Revenue | 159,607 | 136,874 | 220,699 | 196,923 | 153,632 | 97,288 | Upgrade
|
Revenue | 1,142,350 | 1,111,367 | 1,259,946 | 999,759 | 786,946 | 686,184 | Upgrade
|
Revenue Growth (YoY) | -10.48% | -11.79% | 26.02% | 27.04% | 14.68% | 18.35% | Upgrade
|
Cost of Revenue | 337,168 | 413,306 | 476,251 | 338,147 | 273,465 | 266,071 | Upgrade
|
Gross Profit | 805,182 | 698,061 | 783,695 | 661,612 | 513,481 | 420,113 | Upgrade
|
Selling, General & Admin | 108,439 | 112,580 | 100,760 | 102,416 | 94,401 | 101,574 | Upgrade
|
Research & Development | 171,068 | 174,868 | 149,626 | 137,299 | 117,850 | 107,942 | Upgrade
|
Other Operating Expenses | -14,503 | -28,561 | - | - | - | - | Upgrade
|
Operating Expenses | 265,004 | 258,887 | 250,386 | 239,715 | 212,251 | 209,516 | Upgrade
|
Operating Income | 540,178 | 439,174 | 533,309 | 421,897 | 301,230 | 210,597 | Upgrade
|
Interest Expense | -8 | -27 | -61 | -48 | -62 | -125 | Upgrade
|
Interest & Investment Income | - | 4,674 | 52 | - | - | 545 | Upgrade
|
Other Non Operating Income (Expenses) | 47 | - | -2,134 | -2,464 | -2,980 | -3,124 | Upgrade
|
EBT Excluding Unusual Items | 540,217 | 443,821 | 531,166 | 419,385 | 298,188 | 207,893 | Upgrade
|
Pretax Income | 540,217 | 443,821 | 531,166 | 419,385 | 298,188 | 207,893 | Upgrade
|
Income Tax Expense | 153,253 | 118,349 | 156,737 | 116,390 | 83,455 | 50,333 | Upgrade
|
Earnings From Continuing Operations | 386,964 | 325,472 | 374,429 | 302,995 | 214,733 | 157,560 | Upgrade
|
Net Income | 386,964 | 325,472 | 374,429 | 302,995 | 214,733 | 157,560 | Upgrade
|
Net Income to Common | 386,964 | 325,472 | 374,429 | 302,995 | 214,733 | 157,560 | Upgrade
|
Net Income Growth | 14.91% | -13.08% | 23.58% | 41.10% | 36.29% | 70.36% | Upgrade
|
Shares Outstanding (Basic) | 1,645 | 1,645 | 1,645 | 1,644 | 1,643 | 1,642 | Upgrade
|
Shares Outstanding (Diluted) | 1,646 | 1,645 | 1,645 | 1,645 | 1,645 | 1,645 | Upgrade
|
Shares Change (YoY) | 0.01% | 0.01% | 0.01% | 0.01% | 0.03% | 0.05% | Upgrade
|
EPS (Basic) | 235.18 | 197.83 | 227.64 | 184.29 | 130.66 | 95.95 | Upgrade
|
EPS (Diluted) | 235.15 | 197.80 | 227.57 | 184.17 | 130.53 | 95.81 | Upgrade
|
EPS Growth | 14.90% | -13.08% | 23.57% | 41.09% | 36.24% | 70.28% | Upgrade
|
Free Cash Flow | 351,009 | 337,977 | 181,487 | 213,657 | 147,995 | 153,632 | Upgrade
|
Free Cash Flow Per Share | 213.30 | 205.39 | 110.30 | 129.86 | 89.96 | 93.42 | Upgrade
|
Dividend Per Share | 81.000 | 80.000 | 78.000 | 76.000 | 55.000 | 32.000 | Upgrade
|
Dividend Growth | 102.50% | 2.56% | 2.63% | 38.18% | 71.88% | 11.63% | Upgrade
|
Gross Margin | 70.48% | 62.81% | 62.20% | 66.18% | 65.25% | 61.22% | Upgrade
|
Operating Margin | 47.29% | 39.52% | 42.33% | 42.20% | 38.28% | 30.69% | Upgrade
|
Profit Margin | 33.87% | 29.29% | 29.72% | 30.31% | 27.29% | 22.96% | Upgrade
|
Free Cash Flow Margin | 30.73% | 30.41% | 14.40% | 21.37% | 18.81% | 22.39% | Upgrade
|
EBITDA | 567,090 | 470,914 | 564,743 | 452,765 | 331,606 | 236,998 | Upgrade
|
EBITDA Margin | 49.64% | 42.37% | 44.82% | 45.29% | 42.14% | 34.54% | Upgrade
|
D&A For EBITDA | 26,912 | 31,740 | 31,434 | 30,868 | 30,376 | 26,401 | Upgrade
|
EBIT | 540,178 | 439,174 | 533,309 | 421,897 | 301,230 | 210,597 | Upgrade
|
EBIT Margin | 47.29% | 39.52% | 42.33% | 42.20% | 38.28% | 30.69% | Upgrade
|
Effective Tax Rate | 28.37% | 26.67% | 29.51% | 27.75% | 27.99% | 24.21% | Upgrade
|
Revenue as Reported | 1,142,350 | - | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.